Effect of satiety center damage on food intake, blood glucose and gastric secretion in dogs

1972 ◽  
Vol 17 (2) ◽  
pp. 139-148 ◽  
Author(s):  
Yukio Nagamachi
Keyword(s):  
Blood Glucose ◽  
Food Intake ◽  
Gastric Secretion ◽  
Satiety Center

Anti-Diabetic and Angio-Protective Effect of Guluronic Acid (G2013) as a New Nonsteroidal Anti-Inflammatory Drug in the Experimental Model of Diabetes

2020 ◽  
Vol 20 (3) ◽  
pp. 446-452
Author(s):  
Seyed S. Mortazavi-Jahromi ◽  
Shahab Alizadeh ◽  
Mohammad H. Javanbakht ◽  
Abbas Mirshafiey
Keyword(s):  
Gene Expression ◽  
Blood Glucose ◽  
Food Intake ◽  
Experimental Model ◽  
Serum Insulin ◽  
Fasting Blood Glucose ◽  
Diabetic Control ◽  
The Body ◽  
Sprague Dawley ◽  
Guluronic Acid

Background: This study aimed to investigate the effects of guluronic acid (G2013) on blood sugar, insulin, and gene expression profile of oxLDL receptors (SR-A, CD36, LOX-1, and CD68) in the experimental model of diabetes. Methods: 18 Sprague Dawley rats were randomly assigned to three groups of healthy control, diabetic control, and G2013 group. Diabetes was induced through intraperitoneal (IP) injection of 60 mg/kg streptozotocin. The subjects were IP treated with 25 mg/kg of G2013 per day for 28 days. The body weight, food intake, fasting blood glucose and insulin were measured. In addition, the expression of mentioned genes was investigated through quantitative real-time PCR. Results: The data showed that the final weight increased significantly in the G2013-treated subjects compared to the diabetic control (p < 0.05). The results indicated that final food intake significantly reduced in the G2013-treated subjects compared to the diabetic control (p < 0.05). The study findings also suggested that the final fasting blood glucose significantly reduced in the G2013-treated group, whereas the final fasting serum insulin level significantly increased in this group compared to the diabetic control (p < 0.05). Moreover, the gene expression levels of SR-A, CD36, LOX-1, and CD68 in the G2013 group significantly reduced compared to the diabetic control (p < 0.05). Conclusion: This study showed that G2013, could reduce blood glucose and increase insulin levels and reduce the gene expression level of oxLDL receptors. In addition, it may probably play an important role in reducing the severity of diabetes-induced inflammatory symptoms.

Food intake rather than blood glucose levels affects the pharmacokinetic profile of insulin aspart in pigs

2021 ◽  
Author(s):  
Anna Katrina Jógvansdóttir Gradel ◽  
Jonas Kildegaard ◽  
Trine Porsgaard ◽  
Jens Lykkesfeldt ◽  
Hanne Hoffman Frølund Refsgaard
Keyword(s):  
Blood Glucose ◽  
Food Intake ◽  
Insulin Aspart ◽  
Pharmacokinetic Profile ◽  
Glucose Levels ◽  
Blood Glucose Levels

LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications

2006 ◽  
Vol 291 (4) ◽  
pp. G611-G620 ◽  
Author(s):  
Lixin Wang ◽  
Nicole R. Basa ◽  
Almaas Shaikh ◽  
Andrew Luckey ◽  
David Heber ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Gastric Emptying ◽  
Food Intake ◽  
Intravenous Injection ◽  
Plasma Levels ◽  
Inhibitory Action ◽  
Functional Implications ◽  
Urocortin 1 ◽  
Fasted Rats

LPS injected intraperitoneally decreases fasted plasma levels of ghrelin at 3 h postinjection in rats. We characterized the inhibitory action of LPS on plasma ghrelin and whether exogenous ghrelin restores LPS-induced suppression of food intake and gastric emptying in fasted rats. Plasma ghrelin and insulin and blood glucose were measured after intraperitoneal injection of LPS, intravenous injection of IL-1β and urocortin 1, and in response to LPS under conditions of blockade of IL-1 or CRF receptors by subcutaneous injection of IL-1 receptor antagonist (IL-1Ra) or astressin B, respectively, and prostaglandin (PG) synthesis by intraperitoneal indomethacin. Food intake and gastric emptying were measured after intravenous injection of ghrelin at 5 h postintraperitoneal LPS injection. LPS inhibited the elevated fasted plasma ghrelin levels by 47.6 ± 4.9%, 58.9 ± 3.3%, 74.4 ± 2.7%, and 48.9 ± 8.7% at 2, 3, 5, and 7 h postinjection, respectively, and values returned to preinjection levels at 24 h. Insulin levels were negatively correlated to those of ghrelin, whereas there was no significant correlation between glucose and ghrelin. IL-1Ra and indomethacin prevented the first 3-h decline in ghrelin levels induced by LPS, whereas astressin B did not. IL-1β inhibited plasma ghrelin levels, whereas urocortin 1 had no influence. Ghrelin injected intravenously prevented an LPS-induced 87% reduction of gastric emptying and 61% reduction of food intake. These data showed that IL-1 and PG pathways are part of the early mechanisms by which LPS suppresses fasted plasma ghrelin and that exogenous ghrelin can normalize LPS-induced-altered digestive functions.

Localization of hindbrain glucoreceptive sites controlling food intake and blood glucose

2000 ◽  
Vol 856 (1-2) ◽  
pp. 37-47 ◽  
Author(s):  
Sue Ritter ◽  
Thu T. Dinh ◽  
Yubei Zhang
Keyword(s):  
Blood Glucose ◽  
Food Intake

Effects of bombesin on food intake and gastric acid secretion in cats

1989 ◽  
Vol 256 (1) ◽  
pp. R181-R186
Author(s):  
A. Bado ◽  
M. J. Lewin ◽  
M. Dubrasquet
Keyword(s):  
Gastric Emptying ◽  
Food Intake ◽  
Gastric Secretion ◽  
Acid Secretion ◽  
Gastric Fistula ◽  
Single Class ◽  
Heidenhain Pouch ◽  
Daily Food Intake ◽  
Feeding Experiments ◽  
Daily Food

The brain and gut peptide bombesin has been reported both to stimulate gastric secretion and to induce satiety. To understand how the peripheral administration of bombesin affects food intake and whether gastric mechanisms are involved, a comparative study of the doses of bombesin active on gastric secretion, gastric emptying, and food intake was undertaken in cats provided with a gastric fistula and a denervated Heidenhain pouch. The smallest dose of intravenous bombesin that stimulated significantly basal acid secretion (20 pmol.kg-1.h-1) by the gastric fistula also enhanced meal-stimulated acid secretion by the Heidenhain pouch (+138%, P less than 0.01), delayed gastric emptying of a liquid protein meal (-30%, P less than 0.01), and suppressed food intake when the test meal was allowed to reach the stomach (-15%, P less than 0.01). Conversely, in sham-feeding experiments, the same dose of bombesin increased food intake (+35%, P less than 0.01). In full-day experiments conducted in nonfasted cats, bombesin decreased both the food intake in the 4-h period after the infusion and the daily food intake, whereas octapeptide cholecystokinin induced a transient satiety but did not decrease daily food intake. These results indicate that in cats the interaction of bombesin with "pregastric" mechanisms is not sufficient to induce satiety and that a relation could exist between the effects of bombesin on gastric secretion, emptying, and food intake. A single class of receptors might be involved in these peripheral effects of bombesin.

Effects of hormones and hypoglycemic agents on testicular fat in the rat

1961 ◽  
Vol 200 (6) ◽  
pp. 1277-1284 ◽  
Author(s):  
T. C. Smith ◽  
L. Will ◽  
J. Oleson ◽  
K. -F. Benitz ◽  
J. Perrine ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Body Weight ◽  
Blood Glucose ◽  
Food Intake ◽  
Lipid Content ◽  
Fat Body ◽  
Hypoglycemic Agents ◽  
Hydrocortisone Acetate ◽  
Simultaneous Measurements ◽  
Fat Bodies

Response of transplanted and nontransplanted fat bodies to various hormones, tolbutamide, and hypoglycin A was compared by measuring the amount of lipids in the dissected fat bodies after 2 weeks treatment. Simultaneous measurements of food intake and body weight were made to serve as a basis for evaluating the effects on fat. Protamine zinc insulin produced an increase in lipid content of the testicular fat body, accompanied by elevation in food intake in three of five experiments; hydrocortisone acetate, triamcinolone or its 16,21-diacetate, or diethylstilbestrol brought about decreases in lipid with either no change or a decline in food intake; epinephrine·HCl or growth hormone elicited decreases in lipid without significantly influencing food intake or body weight. Generally, transplanted fat was more responsive to these agents than the undisturbed fat body. Both tolbutamide and hypoglycin A decreased lipids in the transplant without affecting those in untransplanted fat. Food intake, body weight, and blood glucose were not changed.

Effects of food intake and composition on the concentration of glucose in the blood of lactating cattle

1977 ◽  
Vol 28 (2) ◽  
pp. 333 ◽  
Author(s):  
TJ McClure
Keyword(s):  
Blood Glucose ◽  
Food Intake ◽  
Rice Straw ◽  
Feed Intake ◽  
Glucose Concentration ◽  
Blood Glucose Concentration ◽  
Metabolizable Energy ◽  
Lactating Cows ◽  
Maize Meal ◽  
Ad Libitum

A group of 16 cows, each suckling one calf, were fed on rations composed of maize meal, cottonseed meal, urea and rice straw in one of four different ratios and at two levels, (a) ad libitum and (b) in restricted amounts. The composition of the feed affected intake. Both the gross intake and the estimated intake of metabolizable energy were closely correlated with liveweight change. The intake of metabolizable energy was correlated with blood glucose in the cows fed ad libitum, but not in the cows fed on restricted amounts of the rations. It was concluded that feed quality significantly affected the blood glucose concentration of the lactating cows, but that within the ranges used in this experiment, feed intake and the intake of metabolizable energy had little effect.

Alterations in gastric secretion following hypothalamic lesions producing hyperphagia

1965 ◽  
Vol 209 (2) ◽  
pp. 319-323 ◽  
Author(s):  
Peter T. Ridley ◽  
Frank P. Brooks
Keyword(s):  
Food Intake ◽  
Gastric Secretion ◽  
Neural Control ◽  
Neural Mechanisms ◽  
Gastric Fistula ◽  
Central Regulation ◽  
Pepsin Secretion ◽  
Insulin Hypoglycemia ◽  
Hypothalamic Lesions

Fasting gastric secretion and secretion during insulin hypoglycemia were collected from hypothalamic hyperphagic rats equipped with chronic gastric fistula in an attempt to correlate the hypothalamic neural mechanisms controlling food intake with gastric secretion. The interdigestive or basal fasting secretion of rats rendered hyperphagic by stereotaxic ablation of the ventromedial nuclei was significantly increased in volume, acid concentration and output, and pepsin output when compared with control and sham-operated rats and rats with hypothalamic lesions without hyperphagia. Hypothalamic hyperphagic rats did not show a significant increase in gastric secretion during insulin hypoglycemia, whereas the other groups did. The levels of hypoglycemia induced by insulin were comparable in all groups. These studies suggest an important role of the ventromedial nuclei in the central regulation of acid and pepsin secretion, and also relate the hypothalamic neural control of gastric secretion to that of food intake. The results also indicate that this nucleus is involved either as a "center" or pathway in the augmentation of gastric secretion by insulin hypoglycemia.

scholarly journals Stevia Beverage Consumption prior to Lunch Reduces Appetite and Total Energy Intake without Affecting Glycemia or Attentional Bias to Food Cues: A Double-Blind Randomized Controlled Trial in Healthy Adults

2020 ◽  
Vol 150 (5) ◽  
pp. 1126-1134 ◽  
Author(s):  
Nikoleta S Stamataki ◽  
Corey Scott ◽  
Rebecca Elliott ◽  
Shane McKie ◽  
Douwina Bosscher ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Food Intake ◽  
Total Energy ◽  
Attentional Bias ◽  
Energy Intake ◽  
Sweet Taste ◽  
Healthy Adults ◽  
Food Cues ◽  
Double Blind ◽  
Randomized Controlled

ABSTRACT Background Stevia is a zero-calorie alternative to caloric sugars. Substituting caloric sweeteners with noncaloric sweeteners reduces available energy, but their effects on appetite, subsequent food intake, and neurocognitive responses are still unclear. Objective The aim was to examine whether sweetness with or without calories influences food intake, appetite, blood glucose concentrations, and attentional bias (AB) to food cues. Methods This was a randomized, controlled, double-blind crossover study. Healthy participants [n = 20; aged 27 ± 5 y,  55% female; BMI (kg/m2): 21.8 ± 1.5] completed 5 visits, consuming 5 study beverages: 330 mL water (control, no sweet taste, no calories) and either 330 mL water containing 40 g glucose or sucrose (sweet taste; calories, both 160 kcal), maltodextrin (no sweet taste; calories, 160 kcal), or 240 ppm stevia (sweet taste, no calories). Glucose and stevia beverages were matched for sweetness. Subjective appetite ratings and blood glucose were measured at baseline and at 15, 30, and 60 min postprandially. At 15 min participants performed a visual-dot probe task to assess AB to food cues; at 30 min, participants were offered an ad libitum lunch; food intake was measured. Results Subjective appetite ratings showed that preload sweetness and calorie content both affected appetite. The total AUC for glycemia was significantly higher after the caloric beverages (mean ± SD: maltodextrin, 441 ± 57.6;  glucose, 462 ± 68.1;  sucrose, 425 ± 53.6 mmol × min × L−1 ) compared with both stevia (320 ± 34.2 mmol × min × L−1) and water (304 ± 32.0 mmol × min × L−1) (all P &lt; 0.001). Total energy intake (beverage and meal) was significantly lower after the stevia beverage (727 ± 239 kcal) compared with water (832 ± 198 kcal,  P = 0.013), with no significant difference between the water and caloric beverages (P = 1.00 for water vs. maltodextrin, glucose, and sucrose). However, food-related AB did not differ across conditions (P = 0.140). Conclusions This study found a beneficial and specific effect of a stevia beverage consumed prior to a meal on appetite and energy intake in healthy adults. This trial is registered at clinicaltrials.gov as NCT03711084.

Sign in / Sign up

Export Citation Format

Share Document